Product NDC: | 43386-670 |
Proprietary Name: | Pentazocine Hydrochloride and Acetaminophen |
Non Proprietary Name: | Pentazocine Hydrochloride and Acetaminophen |
Active Ingredient(s): | 650; 25 mg/1; mg/1 & nbsp; Pentazocine Hydrochloride and Acetaminophen |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43386-670 |
Labeler Name: | GAVIS Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076202 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110511 |
Package NDC: | 43386-670-01 |
Package Description: | 100 TABLET in 1 BOTTLE (43386-670-01) |
NDC Code | 43386-670-01 |
Proprietary Name | Pentazocine Hydrochloride and Acetaminophen |
Package Description | 100 TABLET in 1 BOTTLE (43386-670-01) |
Product NDC | 43386-670 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentazocine Hydrochloride and Acetaminophen |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110511 |
Marketing Category Name | ANDA |
Labeler Name | GAVIS Pharmaceuticals, LLC |
Substance Name | ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE |
Strength Number | 650; 25 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |